29 NHS Trusts Listed as Palantir AI Beneficiaries Barely Use the System
NHS England's £330m Palantir data platform sits largely idle at dozens of trusts publicly listed as beneficiaries, a Guardian investigation finds.
More than two dozen hospital trusts that NHS England officially credits as benefiting from Palantir's federated data platform are in fact making little or no use of the AI-powered system, according to a Guardian investigation. The 29 trusts named on NHS England's public list as "realising benefits" from the platform told the Guardian the technology is either not live at their sites or they have not deployed any of its applications.
The revelation exposes a significant disconnect between the health service's public messaging and the on-the-ground reality at those institutions. NHS England awarded Palantir a £330 million contract for the federated data platform, a system designed to aggregate and analyze patient data across the health service. The contract has been controversial since it was announced, drawing scrutiny over data privacy and the role of a U.S. defense-linked technology company in Britain's public health infrastructure.
Read more Prediction Markets Pose as Populist Tools While Elites Dominate →
One senior health official described the gap between NHS England's characterization and the trusts' own accounts as "very misleading," a pointed rebuke that suggests awareness of the discrepancy at senior levels of the organization. The trusts' responses indicate the platform has not achieved the operational rollout its public billing implies.
The findings raise questions about accountability and transparency in large government technology contracts, particularly those involving sensitive medical records. Critics of the Palantir deal have long argued that the procurement process lacked sufficient scrutiny, and the latest disclosures are likely to intensify calls for a formal review of how the platform's deployment and impact are being measured and reported to the public.
Continue reading at Business | The Guardian.